Edition:
United Kingdom

Adamis Pharmaceuticals Corp (ADMP.OQ)

ADMP.OQ on NASDAQ Stock Exchange Capital Market

2.26USD
21 Mar 2019
Change (% chg)

-- (--)
Prev Close
$2.26
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
75,696
52-wk High
$5.10
52-wk Low
$2.03

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.17 December 22 Mar 2019

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 0 0 0 0
(2) OUTPERFORM 2 2 2 2
(3) HOLD 1 1 1 1
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 2.33 2.33 2.33 2.33

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Mar-19 3 5.79 6.29 4.90 --
Quarter Ending Jun-19 3 6.12 7.28 5.29 --
Year Ending Dec-19 3 25.56 30.00 22.60 38.84
Year Ending Dec-20 2 36.83 42.87 30.80 53.38
Earnings (per share)
Quarter Ending Mar-19 2 -0.17 -0.16 -0.17 --
Quarter Ending Jun-19 2 -0.16 -0.14 -0.18 --
Year Ending Dec-19 3 -0.63 -0.56 -0.69 -0.33
Year Ending Dec-20 2 -0.46 -0.40 -0.52 -0.16

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Dec-18 5.47 4.15 1.31 24.00
Quarter Ending Sep-18 5.23 3.83 1.39 26.65
Quarter Ending Jun-18 3.98 3.92 0.06 1.57
Quarter Ending Mar-18 3.58 3.18 0.40 11.08
Quarter Ending Dec-17 4.11 2.84 1.27 30.82

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Mar-19 5.79 5.63 5.63 5.63 --
Quarter Ending Jun-19 6.12 6.71 6.71 6.71 --
Year Ending Dec-19 25.56 27.82 27.82 27.82 38.84
Year Ending Dec-20 36.83 43.29 43.29 40.60 53.38

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Mar-19 1 2 1 2
Quarter Ending Jun-19 0 3 0 3
Year Ending Dec-19 0 2 0 2
Year Ending Dec-20 0 2 0 2
Earnings